TABLE 2.
Clinical and immunologic parameters of malaria patients and healthy donors
| Patient ID | Sex/Age | Days since start of symptoms | Initial parasitemia (%) | CRP (mg/l) | Hemoglobin (g/dl) | Thrombocytes (1000/μl) | Number of malaria episodes | Therapy |
|---|---|---|---|---|---|---|---|---|
| M1 | m 62 | 10 | <1 | 173 | 12.6 | 53 | Euratesim® | |
| M2 | m 49 | 6 | <1 | 110 | 14 | 115 | >1 | Euratesim® |
| M3 | m 62 | 2 | 2.4 | 118 | 12 | 123 | Atovaquon/Proguanil | |
| M4 | m 37 | 5 | <1 | 256 | 13.6 | 50 | Euratesim® | |
| M5 | m 72 | 10 | 18 | 169 | 10.8 | 106 | >1 | Arthemeter/Lumefantrin |
| M6 | w 47 | 14 | 10 | 170 | 10 | 91 | Atovaquon/Proguanil | |
| M7 | m 51 | 11 | 2.5 | 54 | 12.9 | 123 | Euartesim® | |
| M8 | m 68 | 21 | >1 | 51 | 10.9 | 155 | >1 | Atovaquon/Proguanil |
| M9 | m 71 | 3 | >1 | 60 | 11 | 114 | Atovaquon/Proguanil | |
| M10 | m 36 | > 14 | 2 | 58 | 10.5 | 155 | >1 | Artesunate/Lumefantrin |
| M11 | m 54 | 3 | <1 | 223 | 14.2 | 88 | Euratesim® | |
| M12 | w 52 | 5 | 3-4 | 56 | 12.1 | 50 | Euratesim® | |
| Mean | 55,1 | 8.7 | 3.7 | 124.8 | 12.05 | 101.9 | ||
| Median | 53 | 8 | 1.5 | 114 | 12.05 | 110 | ||
| HD1 | w 25 | |||||||
| HD2 | w 30 | |||||||
| HD3 | m 46 | |||||||
| HD4 | w 30 | |||||||
| HD5 | m 28 | |||||||
| HD6 | m 35 | |||||||
| HD7 | w 37 | |||||||
| HD8 | w 29 | |||||||
| HD9 | w 31 | |||||||
| HD10 | m 51 | |||||||
| HD11 | w 46 | |||||||
| HD12 | w 25 | |||||||
| HD13 | w 26 | |||||||
| HD14 | w 30 | |||||||
| HD15 | n.a. | |||||||
| Mean | 33.5 | |||||||
| Median | 30 |
n.a., not acquired; m, man; w, woman.